Israel Active

Hebrew University of Jerusalem Professor Motti Chevion has developed Zygosid-50, the first treatment to restore near-normal cellular sensitivity to insulin, without side effects. Israel’s Concenter BioPharma is preparing to trial Zygosid-50 and give new hope to Type 2 diabetics.

The wearable wristband from Israel’s CardiaCare treats atrial fibrillation (rapid and irregular heartbeats). It combines advanced sensors, AI algorithms and neuromodulation stimulus to restore heart rate and rhythm. CardiaCare won 2019 Innovation in Cardiovascular Interventions Technology.

Several Israeli companies have AI technology to detect health issues by monitoring the voice of the patient. Now, two of them (Beyond Verbal and Healthymize) have merged to form Vocalis Health. Its initial focus is on cardiovascular and respiratory conditions.

Israel is building a new medical center in Sha’ar Binyamin, Samaria, about 15 minutes from Jerusalem. It will serve the 150,000 residents of Binyamin, Israel’s largest region, where a new medical school opened in Ariel recently. The hospital will save many lives, as the video explains.

Israel’s Health Ministry has approved a 3-year pilot program for early detection of lung cancer. Those at high-risk of lung cancer (age 55 – 75, heavy smokers and ex-smokers) will receive low-intensity CT scans. It could save many of Israel’s 1,800 lung cancer deaths each year.

Israel’s Ibex Medical has deployed its Second Read cancer diagnostic system at Israel’s Maccabi  Health company. It is the first Artificial Intelligence-powered lab for diagnosis of breast cancer biopsies.

Israel’s Microbot Medical previously demonstrated a prototype of its self-cleaning shunt for cleaning blockages in the brain . At the J.P. Morgan Healthcare Conference, Microbot demonstrated LIBERTY - the world’s first fully disposable robotic system for endovascular procedures.

Scientists at Israel’s Technion Institute built a 3D model of the lungs of a premature baby. They discovered that in standard respirators for babies an air jet could cause damage to the infant. They have now recommended reconfiguring the air flow, potentially saving many young lives.

Israel’s NovaSight has developed two products: EyeSwift uses eye-tracking technology to detect multiple vision problems in children (e.g. lazy-eye and squints). CureSight treats lazy-eye using 3D image algorithms and variable focusing, while the child watches entertaining videos.

Israel’s RSIP Vision has developed an Artificial Intelligence-based image analysis solution for tissue diagnosis.  It assists doctors in multiple medical imaging fields: e.g. cardiology, pulmonology, ophthalmology, orthopedics, radiology, robotic surgery, microscopy and more.